GlassScriptPhysician profile
Tracey E Sloan
NPI 1144772708
$1,936.82
in general payments reported to CMS, 2019-2025
20 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.82 · 2022: $807 · 2023: $270 · 2024: $322 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.85 |
| Education | $249.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $459.50 | 2022-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $431.61 | 2022-2024 | Erleada |
| Pfizer INC. | $189.56 | 2022-2025 | |
| Abbvie INC. | $144.19 | 2022-2025 | |
| Seagen INC. | $84.99 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $79.14 | 2021-2022 | |
| Urovant Sciences INC | $77.47 | 2021-2022 | |
| Axonics, INC. | $61.15 | 2022-2023 | Bulkamid, Axonics |
| Sumitomo Pharma America, INC. | $57.63 | 2023-2025 | Gemtesa |
| Coloplast Corp | $53.22 | 2025 | |
| Novartis Pharmaceuticals Corporation | $52.09 | 2025 | |
| Urogen Pharma, INC. | $51.62 | 2025 | |
| Boston Scientific Corporation | $48.61 | 2022 | |
| Medtronic, INC. | $35.75 | 2023 | Interstim |
| Endo Pharmaceuticals INC. | $22.61 | 2024 | Aveed, Xiaflex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $21.06 | 2024 | |
| Dendreon Pharmaceuticals LLC | $20.63 | 2024 | Provenge |
| Genentech USA, INC. | $17.23 | 2021 | |
| Tolmar, INC. | $14.90 | 2023 | |
| 180 Medical, INC. | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Sloan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.